---
$id: https://graph.org.ai/products/commodity/51271913
$type: Product
source: UNSPSC
code: "51271913"
title: "Proparacaine or proxymetacaine"
class: "51271900"
classTitle: "Anaesthetic aminobenzoates"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Proparacaine or proxymetacaine

**UNSPSC Code**: 51271913
**Class**: [Anaesthetic aminobenzoates](Anaesthetic aminobenzoates.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C16H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B4OB0JHI1X, chemically known as benzoic acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl ester but generally known as proxymetacaine, which bears US NIH Compound Identifier 4935. European Medicines Agency schedules Proxymetacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10152MIG. The term PROXYMETACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules proparacaine in its Anatomical Therapeutic Chemical (ATC) Classification. Proparacaine or proxymetacaine bears US NLM identifiers UMLS ID C0072510 and NCI Concept Code C61910. SMILES: CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.

